June 2015
Volume 56, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2015
Impact of membrane associated mucin and diquafosol on the wettability of human corneal epithelium cell layers
Author Affiliations & Notes
  • Georgi Asenov Georgiev
    Biochemistry, Sofia University ""St Kliment Ohridski"", Sofia, Bulgaria
  • Norihiko Yokoi
    Department of Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto, Japan
  • Petar Eftimov
    Biochemistry, Sofia University ""St Kliment Ohridski"", Sofia, Bulgaria
  • Nadezhda Stefanova
    Cytology, Histology and Embryology, Sofia University ""St Kliment Ohridski"", Sofia, Bulgaria
  • Slavyana Ivanova
    Biochemistry, Sofia University ""St Kliment Ohridski"", Sofia, Bulgaria
  • Footnotes
    Commercial Relationships Georgi Georgiev, Santen Pharmaceutical Co., Ltd., Osaka, Japan (F); Norihiko Yokoi, None; Petar Eftimov, None; Nadezhda Stefanova, None; Slavyana Ivanova, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2015, Vol.56, 294. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Georgi Asenov Georgiev, Norihiko Yokoi, Petar Eftimov, Nadezhda Stefanova, Slavyana Ivanova; Impact of membrane associated mucin and diquafosol on the wettability of human corneal epithelium cell layers. Invest. Ophthalmol. Vis. Sci. 2015;56(7 ):294.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: The integrity of corneal epithelium glycocalyx is considered of key importance for the wetting of the ocular surface and for the tear film stability. In order to quantitatively evaluate the contribution of membrane associated mucin, MAM, to corneal wetting the changes in the wettability were measured of human corneal epithelium cell (HCEC) layers: (i) intact, (ii) after shedding of MAM (the glycocalyx main constituent) and (iii) subsequent treatment with diquafosol, DQS (MAM expression enhancing drug).

Methods: HCEC cells were cultured to a confluent layer in Keratinocyte-SFM media subsequently switched to DMEM-F12 with 10% FBS and 10 ng/ml EGF. MAM shedding was performed via 30 min exposition to 5 µg/ml neutrophil elastase (NE). The NE-exposed cells were then treated for 1 h with 3% DQS. HCEC viability at each step was verified by MTT test. MAM expression was evaluated via immunofluorescence (OC125 targeted Anti-MUC16 conjugated with Alexa Fluor® 488 Goat Anti-Mouse IgG) and rose bengal (RB) staining. The wettability of HCEC layers kept in solution was probed through measuring of the equilibrium (θE), advancing (θA) and receding (θR) contact angles (CA) by axisymmetric sessile bubble shape analysis. At least 7 measurements were performed with each sample, 1 h and 24 h after treatments.

Results: Intact HCEC cells displayed continuous glycocalyx, resistance to RB staining and low CA (θE=34.03°±3.61° (SD), θA=37.08°±3.12°, θR=32.17°±2.99°). NE-exposed HCEC layers revealed decreased MAM expression, increased RB staining and significant (P<0.05) CA increase (θE=43.60°±3.15°, θA=48.87°±3.17°, θR=40.346°±3.08° at 1 h after treatment; θE=39.78°±2.48°, θA=41.097°±2.34°, θR=36.27°±2.55° at 24 h after treatment). The DQS treatment of NE-exposed cells resulted in prompt recovery of HCEC layers’ MAM expression, resistance to RB staining and CA (θE=36.87°±2.57°, θA=40.23°±2.47°, θR=35.16°±2.07° at 1 h after treatment and full recovery after 24 h).

Conclusions: The impact of MAM to the normal wettability of corneal epithelium surface is quantitatively evaluated. The wettability replenishment effect of DQS correlates with the data on its capability to rapidly enhance mucin expression in vivo. The relationship of corneal epithelium wettability with MAM integrity might be a major mechanism involved in tear film instability and in dry eye syndrome.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×